{"disease":{"id":"thoracic-tumor","name":"thoracic tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02941458","title":"Thoracic Tumours Register","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Spanish Lung Cancer Group","has_results":false},{"nct_id":"NCT03245788","title":"Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":1053,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT05038254","title":"Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":750,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT03037385","title":"Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":590,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT03966456","title":"Real World Study of Four PD-1 Agents in China","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"The Affiliated Hospital of Qingdao University","has_results":false},{"nct_id":"NCT06333951","title":"Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT05053230","title":"A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":480,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT06840288","title":"Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry","phase":"","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06634706","title":"SCINTIX [BgRT} Using RMRS in Solid and Soft Tissue Tumors","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":96,"lead_sponsor_name":"RefleXion Medical","has_results":false},{"nct_id":"NCT03583086","title":"Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Vanderbilt-Ingram Cancer Center","has_results":true},{"nct_id":"NCT07530133","title":"Clinical Trial on Safety and Efficacy of Thoracoabdominal Endoscopic Surgical System for Pediatric Surgery","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":64,"lead_sponsor_name":"Hangzhou Kangji Weijing Medical Robotics Co., Ltd.","has_results":false},{"nct_id":"NCT05189054","title":"Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT03396614","title":"Detection of (Sub)Clinical Toxicity in Irradiated vs. Non-irradiated Surgically Treated Esophageal Cancer Patients: a Pilot Study (CROSS SECT)","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT06603987","title":"Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30,"lead_sponsor_name":"Stella Pharma Corporation","has_results":false},{"nct_id":"NCT04554173","title":"An Appraisal of Minimal Invasive Surgery for Thoracic Neurogenic Tumour","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Fondation Lenval","has_results":false},{"nct_id":"NCT02897778","title":"Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Syndax Pharmaceuticals","has_results":false},{"nct_id":"NCT02909452","title":"Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Syndax Pharmaceuticals","has_results":false},{"nct_id":"NCT03874455","title":"Tazemetostat Expanded Access Program for Adults With Solid Tumors","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Epizyme, Inc.","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}